KTTA Pasithea Therapeutics reports steep Q4 2025 EPS miss far below analyst estimates even as stock edges higher CBLL CeriBell reports narrower Q4 2025 loss than expected as shares dip 085 in daily trading Rail RVSNW Stock Driving Performance Crashes 20260420